The MonumenTAL-6 results add to the growing body of evidence touting Talvey and Tecvayli’s use in earlier multiple myeloma treatment lines.

Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...

Single datacenter and just three services taken down by ‘upstream’ power problem, while the rest of a zone and region kept ...

Bristol Myers Squibb has moved to take full control of the CAR-T therapy it partners with 2seventy bio, agreeing to buy the biotech for around $286 million. The $5.00-per-share offer – announced at ...

Minister of State for Electronics and Information Technology Jitin Prasada informed the Lok Sabha that the government acted ...

In September 2025, IIM Ahmedabad opened a full-fledged international branch campus in Dubai. Offering its flagship one-year ...

At the heart of this technological shift is the rechargeable battery—a sophisticated electrochemical system capable of multiple charge and discharge cycles. Driven primarily by lithium-ion, lithium ...

Bristol Myers Squibb (BMS) has signed a strategic agreement with Anthropic to implement its Claude platform across its global operations. The initiative will embed agentic capabilities throughout BMS’ ...

Discover why more off-grid projects are adopting integrated energy storage systems to improve energy reliability, simplify ...

Researchers developed a continuous-time AI framework for adaptive energy control across multi-zone building profiles using ...

The German automaker is unlikely to be barred, but Volvo and Lotus could potentially be at risk if the bill passes.

Bristol Myers Squibb (BMS) has agreed to acquire its longtime cell therapy partner 2seventy bio in a deal valued at $286m. Announced after markets closed on 10 March, the $5-per-share offer represents ...